GlassScriptPhysician profile
Kishen Patel
NPI 1740817519
$4,360.75
in general payments reported to CMS, 2019-2025
23 companies · $1,475 in 2025
The $1,475 reported for 2025 was more than what 96% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $55.93 · 2023: $1,342 · 2024: $1,488 · 2025: $1,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,263 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $42.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,262.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $42.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,128.46 | 2023-2025 | General - Therapies, Cds Broad Portfolio Offering, General - Stents |
| Abiomed | $736.89 | 2023-2025 | Impella |
| Abbott Laboratories | $389.78 | 2023-2025 | Jot Dx, Assurity, Confirm Rx |
| Penumbra, INC. | $141.76 | 2023 | Indigo System |
| Pfizer INC. | $130.84 | 2024 | |
| Merck Sharp & Dohme LLC | $130.78 | 2022-2025 | Verquvo, Winrevair |
| Stryker Corporation | $113.21 | 2025 | Flowtriever |
| Chiesi USA, INC. | $111.65 | 2023 | Kengreal |
| Philips North America LLC | $88.52 | 2024 | (Bh4) Igt Devices Undivided |
| Novartis Pharmaceuticals Corporation | $74.22 | 2023-2024 | |
| Angiodynamics, INC. | $50.96 | 2025 | Alphavac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.55 | 2024-2025 | Lifevest |
| Depuy Synthes Sales INC. | $24.55 | 2025 | |
| Lundbeck LLC | $23.26 | 2022 | |
| Esperion Therapeutics, INC. | $22.00 | 2024 | Nexletol |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $21.27 | 2024 | |
| Xeris Pharmaceuticals, INC. | $19.79 | 2023 | Gvoke Hypopen |
| Cordis US Corp. | $19.61 | 2024 | Mynxgrip |
| Theratechnologies INC. | $19.36 | 2023 | Trogarzo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.25 | 2024 | Jardiance |
| Novo Nordisk INC | $17.73 | 2024 | Ozempic |
| Baxter Healthcare | $16.82 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Dexcom, INC. | $15.49 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kishen Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.